Regulation of human skin homeostasis by histone arginine methylation regulators

组蛋白精氨酸甲基化调节剂对人类皮肤稳态的调节

基本信息

  • 批准号:
    8448767
  • 负责人:
  • 金额:
    $ 5.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-04-01 至 2014-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Epidermal homeostasis is disrupted in a host of human skin diseases, including psoriasis, chronic wounds, and cancer. Increased understanding of the gene regulatory control of epidermal growth and differentiation by epigenetic regulators, specifically histone arginine methyltransferase PRMT1 and histone arginine demethylase JMJD6, is the central focus of this training plan. First, we will define the role of the histone arginine demethylase JMJD6, which demethylates histone H4 Arginine 3 dimethylation (H4R3me2), in epidermal homeostasis. In our preliminary studies, we observed that the histone mark H4R3me2 is dynamically regulated during human keratinocyte differentiation. In cultured primary human keratinocytes, loss of the H4R3me2 histone arginine demethylase JMJD6 impairs calcium- induced differentiation. To extend these findings, we will define the role of JMJD6 in normal human epidermal tissue homeostasis at the level of intact tissue, leveraging the human tissue regeneration models established in our laboratory. We will also characterize the action of JMJD6 in epidermal growth and differentiation. Second, we will elucidate the role of the histone arginine methyltransferase PRMT1, which methylates histone H4R3, in early progression towards epidermal neoplasia. We recently observed that PRMT1 is required to suppress epidermal differentiation. Loss of PRMT1 by multiple validated short-hairpin RNAs (shRNAs) inhibits proliferation and induces differentiation marker gene expression. Furthermore, PRMT1 is overexpressed in multiple human cancer tissues. Since the first steps in tumor evolution is characterized by alterations in growth and differentiation, we hypothesize that PRMT1 is required for tissue progression toward neoplasia. We will therefore define the role of PRMT1 in epidermis undergoing neoplastic transformation. At the end of the proposed funding period, we hope to have characterized the mechanistic actions of both JMJD6 and PRMT1 gene regulatory proteins in the control of epidermal proliferation and differentiation as a foundation for the future development of new treatment strategies for human disorders of characterized by disrupted epidermal homeostasis.
描述(申请人提供):表皮动态平衡在许多人类皮肤病中被破坏,包括牛皮癣、慢性伤口和癌症。通过表观遗传调节,特别是组蛋白精氨酸甲基转移酶PRMT1和组蛋白精氨酸去甲基酶JMJD6,增加对表皮生长和分化的基因调控的了解,是本培训计划的中心重点。首先,我们将确定组蛋白精氨酸去甲基酶JMJD6,它使组蛋白H4精氨酸3二甲基化(H4R3me2)去甲基化,在表皮动态平衡中的作用。在我们的初步研究中,我们观察到组蛋白标记H4R3me2在人类角质形成细胞分化过程中受到动态调节。在原代培养的人角质形成细胞中,H4R3me2组蛋白精氨酸去甲基酶JMJD6的缺失会削弱钙诱导的分化。为了扩展这些发现,我们将利用我们实验室建立的人类组织再生模型,在完整组织水平上定义JMJD6在正常人类表皮组织动态平衡中的作用。我们还将研究JMJD6在表皮生长和分化中的作用。其次,我们将阐明组蛋白精氨酸甲基转移酶PRMT1,其甲基化组蛋白H4R3,在早期进展为表皮肿瘤中的作用。我们最近观察到PRMT1是抑制表皮分化所必需的。多个有效的短发夹状RNA(ShRNAs)缺失PRMT1可抑制细胞增殖并诱导分化标记基因的表达。此外,PRMT1在多种人类肿瘤组织中过表达。由于肿瘤进化的第一步以生长和分化的改变为特征,我们假设PRMT1是组织向肿瘤进展所必需的。因此,我们将确定PRMT1在经历肿瘤转化的表皮中的作用。在拟议的资助期结束时,我们希望能够表征JMJD6和PRMT1基因调控蛋白在控制表皮增殖和分化中的机制作用,为未来开发以表皮动态平衡被破坏为特征的人类疾病的新治疗策略奠定基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xiaomin Bao其他文献

Xiaomin Bao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xiaomin Bao', 18)}}的其他基金

Epidermal Gene Regulation by Transcription Elongation and Termination
通过转录延伸和终止调节表皮基因
  • 批准号:
    10460273
  • 财政年份:
    2020
  • 资助金额:
    $ 5.57万
  • 项目类别:
Epidermal Gene Regulation by Transcription Elongation and Termination
通过转录延伸和终止调节表皮基因
  • 批准号:
    9887603
  • 财政年份:
    2020
  • 资助金额:
    $ 5.57万
  • 项目类别:
Epidermal Gene Regulation by Transcription Elongation and Termination
通过转录延伸和终止调节表皮基因
  • 批准号:
    10698015
  • 财政年份:
    2020
  • 资助金额:
    $ 5.57万
  • 项目类别:
Epidermal Gene Regulation by Transcription Elongation and Termination
通过转录延伸和终止调节表皮基因
  • 批准号:
    10261355
  • 财政年份:
    2020
  • 资助金额:
    $ 5.57万
  • 项目类别:
Regulators of Epidermal Gene Expression
表皮基因表达的调节因子
  • 批准号:
    8617407
  • 财政年份:
    2014
  • 资助金额:
    $ 5.57万
  • 项目类别:
Regulation of human skin homeostasis by histone arginine methylation regulators
组蛋白精氨酸甲基化调节剂对人类皮肤稳态的调节
  • 批准号:
    8249334
  • 财政年份:
    2011
  • 资助金额:
    $ 5.57万
  • 项目类别:
Regulation of human skin homeostasis by histone arginine methylation regulators
组蛋白精氨酸甲基化调节剂对人类皮肤稳态的调节
  • 批准号:
    8125807
  • 财政年份:
    2011
  • 资助金额:
    $ 5.57万
  • 项目类别:

相似海外基金

Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
  • 批准号:
    EP/Y000331/1
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
  • 批准号:
    10677295
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
  • 批准号:
    10635599
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
  • 批准号:
    10752320
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
  • 批准号:
    478927
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
  • 批准号:
    10855703
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
  • 批准号:
    10654210
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
  • 批准号:
    10667952
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
  • 批准号:
    10726986
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了